Research & Development

开心五月丁香五月乱伦图猪价8月有望突破历史高位 生猪行情远未结束


八三 九八开心五月 堇浦先生曰︰“馮鈍吟右西昆而黜西江,固矣!夫西昆沿于晚唐,西江盛于南宋;今將禁晉、魏之不為齊、梁,禁齊、梁之不為開元、大歷,此必不得之數。風會流傳,人聲因之,合三千年之人,為一朝之詩,有是理乎?二馮可謂能持詩之正,未可謂遂盡其變者也。”丁香五月 一二 乱伦图 八七

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo